
Innovative DNA-based immunotherapy shows promise, achieving over five years of recurrence-free survival in patients with aggressive brain and liver cancers.
Paige Britt is an assistant editor for Targeted Oncology covering gyencologic cancers and lyphomas. Contact her at pbritt@targetedonc.com.